Literature DB >> 28087226

Pathways to limit group 2 innate lymphoid cell activation.

Taylor A Doherty1, David H Broide2.   

Abstract

Entities:  

Keywords:  Group 2 innate lymphoid cell; activation

Mesh：

Substances：

Year:  2017        PMID： 28087226      PMCID： PMC5605226          DOI： 10.1016/j.jaci.2016.12.003

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  14 in total

1.  IL-27 suppresses type 2 immune responses in vivo via direct effects on group 2 innate lymphoid cells.

Authors:  T Mchedlidze; M Kindermann; A T Neves; D Voehringer; M F Neurath; S Wirtz
Journal:  Mucosal Immunol       Date:  2016-03-16       Impact factor: 7.313

2.  Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid Cell Responses.

Authors:  Weisong Zhou; Shinji Toki; Jian Zhang; Kasia Goleniewksa; Dawn C Newcomb; Jacqueline Y Cephus; Daniel E Dulek; Melissa H Bloodworth; Matthew T Stier; Vasiliy Polosuhkin; Rama D Gangula; Simon A Mallal; David H Broide; R Stokes Peebles
Journal:  Am J Respir Crit Care Med       Date:  2016-01-01       Impact factor: 21.405

3.  Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness.

Authors:  Hannah H Walford; Sean J Lund; Rachel E Baum; Andrew A White; Christopher M Bergeron; Jacob Husseman; Kelly J Bethel; David R Scott; Naseem Khorram; Marina Miller; David H Broide; Taylor A Doherty
Journal:  Clin Immunol       Date:  2014-09-16       Impact factor: 3.969

Review 4.  At the bench: understanding group 2 innate lymphoid cells in disease.

Authors:  Taylor A Doherty
Journal:  J Leukoc Biol       Date:  2014-12-03       Impact factor: 4.962

5.  ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity.

Authors:  Hadi Maazi; Nisheel Patel; Ishwarya Sankaranarayanan; Yuzo Suzuki; Diamanda Rigas; Pejman Soroosh; Gordon J Freeman; Arlene H Sharpe; Omid Akbari
Journal:  Immunity       Date:  2015-03-10       Impact factor: 31.745

6.  Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma.

Authors:  Cindy Barnig; Manuela Cernadas; Stefanie Dutile; Xiaoli Liu; Mark A Perrella; Shamsah Kazani; Michael E Wechsler; Elliot Israel; Bruce D Levy
Journal:  Sci Transl Med       Date:  2013-02-27       Impact factor: 17.956

7.  Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production.

Authors:  Taylor A Doherty; Naseem Khorram; Sean Lund; Amit Kumar Mehta; Michael Croft; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2013-05-17       Impact factor: 10.793

8.  Id2 and Id3 maintain the regulatory T cell pool to suppress inflammatory disease.

Authors:  Masaki Miyazaki; Kazuko Miyazaki; Shuwen Chen; Manami Itoi; Marina Miller; Li-Fan Lu; Nissi Varki; Aaron N Chang; David H Broide; Cornelis Murre
Journal:  Nat Immunol       Date:  2014-06-29       Impact factor: 25.606

9.  The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation.

Authors:  Shinji Toki; Kasia Goleniewska; Sara Reiss; Weisong Zhou; Dawn C Newcomb; Melissa H Bloodworth; Matthew T Stier; Kelli L Boyd; Vasiliy V Polosukhin; Sriram Subramaniam; R Stokes Peebles
Journal:  Thorax       Date:  2016-04-12       Impact factor: 9.139

10.  Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity.

Authors:  Lauriane Galle-Treger; Yuzo Suzuki; Nisheel Patel; Ishwarya Sankaranarayanan; Jennifer L Aron; Hadi Maazi; Lin Chen; Omid Akbari
Journal:  Nat Commun       Date:  2016-10-18       Impact factor: 14.919
View more
  7 in total

1.  Platelets attach to lung type 2 innate lymphoid cells (ILC2s) expressing P-selectin glycoprotein ligand 1 and influence ILC2 function.

Authors:  Maya R Karta; Kellen Cavagnero; Marina Miller; Jana Badrani; Luay Naji; Taylor A Doherty; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2019-06-12       Impact factor: 10.793

2.  BAL Cell Gene Expression in Severe Asthma Reveals Mechanisms of Severe Disease and Influences of Medications.

Authors:  Nathaniel Weathington; Michael E O'Brien; Josiah Radder; Thomas C Whisenant; Eugene R Bleecker; William W Busse; Serpil C Erzurum; Benjamin Gaston; Annette T Hastie; Nizar N Jarjour; Deborah A Meyers; Jadranka Milosevic; Wendy C Moore; John R Tedrow; John B Trudeau; Hesper P Wong; Wei Wu; Naftali Kaminski; Sally E Wenzel; Brian D Modena
Journal:  Am J Respir Crit Care Med       Date:  2019-10-01       Impact factor: 21.405

Review 3.  Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches.

Authors:  Atsushi Kato; Anju T Peters; Whitney W Stevens; Robert P Schleimer; Bruce K Tan; Robert C Kern
Journal:  Allergy       Date:  2021-09-15       Impact factor: 14.710

4.  Cytokine and Lipid Mediator Regulation of Group 2 Innate Lymphoid Cells (ILC2s) in Human Allergic Airway Disease.

Authors:  Kellen Cavagnero; Taylor A Doherty
Journal:  J Cytokine Biol       Date:  2017-08-04

Review 5.  Advancements in Host-Based Interventions for Influenza Treatment.

Authors:  Tsz-Fung Yip; Aisha Sami Mohammed Selim; Ida Lian; Suki Man-Yan Lee
Journal:  Front Immunol       Date:  2018-07-10       Impact factor: 7.561

Review 6.  The Role of Type 2 Innate Lymphoid Cells in Allergic Diseases.

Authors:  Haocheng Zheng; Yi Zhang; Jiachuang Pan; Nannan Liu; Yu Qin; Linghui Qiu; Min Liu; Tieshan Wang
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

7.  Mesenchymal stem cells regulate type 2 innate lymphoid cells via regulatory T cells through ICOS-ICOSL interaction.

Authors:  Xingliang Fan; Zhi-Bin Xu; Cheng-Lin Li; Hong-Yu Zhang; Ya-Qi Peng; Bi-Xin He; Xiao-Qing Liu; De-Hua Chen; Dong Chen; Cezmi A Akdis; Qing-Ling Fu
Journal:  Stem Cells       Date:  2021-03-19       Impact factor: 6.277
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.